| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |